REGULATED PRESS RELEASE published on 04/09/2024 at 07:15, 2 years 2 months ago bioMérieux presents its new 5-year strategic plan and its targets for profitable growth bioMérieux unveils its 5-year strategic plan, GO•28, aimed at sustainable growth and responsiblity. Targets include +7% organic revenue growth and -50% GHG emissions by 2030 BioMérieux Strategic Plan Organic Growth GHG Emissions GO•28
REGULATED PRESS RELEASE published on 04/09/2024 at 07:15, 2 years 2 months ago bioMérieux présente son nouveau plan stratégique à 5 ans et son objectif de croissance rentable bioMérieux présente son nouveau plan stratégique GO•28 visant une croissance rentable et durable pour les 5 prochaines années BioMérieux Plan Stratégique Diagnostic In Vitro Croissance Rentable GO•28
BRIEF published on 04/09/2024 at 07:06, 2 years 2 months ago BioMérieux annonce une croissance robuste au premier trimestre 2024 BioMérieux Diagnostic In Vitro Croissance Des Ventes BIOFIRE SPOTFIRE
BRIEF published on 04/09/2024 at 07:06, 2 years 2 months ago BioMérieux Posts Strong First-Quarter 2024 Results with Outstanding Sales Growth BioMérieux In Vitro Diagnostics First-Quarter 2024 BIOFIRE® Panels SPOTFIRE®
REGULATED PRESS RELEASE published on 04/09/2024 at 07:01, 2 years 2 months ago bioMérieux – Information financière du 1er trimestre 2024 bioMérieux a annoncé des ventes en forte croissance de +10% au 1er trimestre 2024, portées par le succès des panels BIOFIRE® et de la solution SPOTFIRE® Croissance BioMérieux Ventes Panels BIOFIRE® Solution SPOTFIRE®
REGULATED PRESS RELEASE published on 04/09/2024 at 07:01, 2 years 2 months ago bioMérieux – First-Quarter 2024 Business Review bioMérieux reports strong +10% organic sales growth in the first quarter of 2024, driven by BIOFIRE® and microbiology segments. Sales reach €965 million. Company confirms 2024 guidance for sales and operating profit BioMérieux Organic Sales Growth 2024 Guidance BIOFIRE® Microbiology
BRIEF published on 04/05/2024 at 09:04, 2 years 2 months ago BioMérieux annonce son nombre d’actions et de droits de vote pour mars 2024 Droits De Vote Capital Social BioMérieux Actions Mars 2024
BRIEF published on 04/05/2024 at 09:04, 2 years 2 months ago BioMérieux announces its number of shares and voting rights for March 2024 Share Capital Voting Rights BioMérieux Actions March 2024
REGULATED PRESS RELEASE published on 04/05/2024 at 08:59, 2 years 2 months ago Mars 2024 - Déclaration sur le nombre d'actions composant le capital social et le nombre de droits de vote correspondant bioMérieux communique les informations mensuelles relatives au nombre total de droits de vote et d'actions au 31/03/2024 Droits De Vote Code De Commerce BioMérieux Actions Informations Mensuelles
BRIEF published on 04/05/2024 at 07:06, 2 years 2 months ago BioMérieux and Mérieux NutriSciences Launch Collaborative Data-Driven Initiative for Food Safety BioMérieux Food Safety Industry Collaboration Data-driven Initiative Consumer Safety
Published on 06/20/2026 at 01:00, 21 hours 12 minutes ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 22 hours 12 minutes ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 17 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 20 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 21 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 47 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 16 hours 12 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 1 hour ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 1 hour ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 3 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 2 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 2 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 2 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 2 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
